A vial and a syringe are seen in front of a displayed Moderna logo.
Moderna Inc could face a patent infringement lawsuit over its COVID-19 vaccine after a federal appeals court rejected its challenge to patents belonging to Arbutus Biopharma Corp.
The Federal Circuit U.S. Court of Appeals said Arbutus’ patents, which may cover technology used in the vaccines, were not obvious, upholding rulings last year by an administrative panel.
Arbutus shares were up $1.22, or 38% higher, at $4.42. Moderna shares fell about 7%.
Moderna and Arbutus did not immediately respond to requests for comment.
Moderna previously said in court filings that it believes Arbutus could bring a lawsuit demanding royalties from its COVID-19 vaccine if the patents are upheld.
A man was arrested after allegedly spraying a chemical substance inside the pro-Palestine encampment at…
Looking to celebrate Cinco de Mayo in Philadelphia in 2024? We’ve got the scoop on…
By BRUCE SHIPKOWSKI Associated Press A decomposed body found earlier this year in a duffel…
A Pennsylvania man who credits an alligator named Wally for helping relieve his depression for…
By JOE REEDY AP Sports Writer Kyle Schwarber had a two-run single in the second…
By MARC LEVY Associated Press Pennsylvania's House of Representatives on Wednesday approved a bill long…
This website uses cookies.